Skip to main content
Medic Debate
- The Antidote to Medical Misinformation and Propaganda!
Languages
Dansk
Nederlands
English
Français
Deutsch
Italiano
Español
Kiswahili
Svenska
Search form
Search
Main menu
Home
Search
About us
Books
Category Search
Log In
Recent posts
Treatment Protocols
You are here
Home
Etoposide
Items per page
5
10
20
40
60
100
Title
Average Rating
Durable responses with the antiangiogenic metronomic regimen RT-PEPC in elderly patients with recurrent mantle cell lymphoma
70.00%
Clinical management of adrenocortical carcinoma
60.00%
Low-dose chemotherapy combined with an antiangiogenic drug reduces human glioma growth in vivo.
80.00%
Antiangiogenic potency of various chemotherapeutic drugs for metronomic chemotherapy.
80.00%
Cisplatin-Based Adjuvant Chemotherapy in Patients with Completely Resected Non–Small-Cell Lung Cancer
50.00%
Different metronomic treatment schedules
80.00%
Durable responses with the metronomic rituximab and thalidomide plus prednisone, etoposide, procarbazine, and cyclophosphamide r
70.00%
Ifosfamide, carboplatin, and etoposide (ICE) in combination with regional hyperthermia (RHT) in chemotherapy-pretreated non.....
40.00%
Impressive survival data with semimetronomic oral chemotherapy with old agents in heavily treated metastatic breast cancer.....
75.00%
Metronomic antiangiogenetic biochemotherapy of non-small cell lung cancer patients ....
80.00%
Regional hyperthermia (RHT) improves response and survival when combined with systemic chemotherapy in the management of local..
80.00%
The PEP-C regimen for recurring/refractory lymphoma: low-dose metronomic, multidrug therapy.
90.00%